Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19846200 | 1.00 | MMP1 (0.50) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL19846192 | 0.91 | MMP1 (0.44) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL19846176 | 0.91 | MMP1 (0.44) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL19846183 | 0.91 | SLC1A3 (0.45) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL12091193 | 0.88 | MMP1 (0.45) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL6892557 | 0.88 | MMP1 (0.67) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL1468445 | 0.86 | MMP1 (0.44) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL8096888 | 0.84 | SLC1A2 (0.54) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL8096897 | 0.84 | SLC1A2 (0.54) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL8096891 | 0.84 | SLC1A2 (0.54) | MMP1MMP2MMP3MMP9MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0514201-A1 | Separation process using organic acids and novel organic acids | Philip Morris Products Inc. (US) | 1992-11-19 | — | — | EP | claimed |
| US-20180037840-A1 | THERMOCLEAVABLE FRICTION MODIFIERS AND METHODS THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2018-02-08 | — | — | US | disclosed |
| US-7358384-B2 | Processes for the recovery of optically active diacyltartaric acids | TORAY FINE CHEMICALS CO., LTD. (JP) | 2008-04-15 | — | — | US | disclosed |
| US-20060058546-A1 | Processes for the recovery of optically active diacyltartatic acids | TORAY FINE CHEMICALS CO., LTD. (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-1586551-A1 | PROCESSES FOR THE RECOVERY OF OPTICALLY ACTIVE DIACYLTARTATIC ACIDS | Toray Fine Chemicals Co., Ltd. (JP) | 2005-10-19 | — | — | EP | disclosed |
| WO-1995005154-A1 | CLEANSING COMPOSITION | UNILEVER PLC (GB) | 1995-02-23 | — | — | WO | disclosed |
| EP-0354068-B1 | Optically active piperazine derivative | NIPPON CHEMIPHAR CO (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-4978666-A | INCREASED CEREBRAL CIRCULATION; ANTICOAGULANTS | NIPPON CHEMIPHAR CO., LTD. (JP) | 1990-12-18 | — | — | US | disclosed |
| EP-0354068-A2 | Optically active piperazine derivative | NIPPON CHEMIPHAR CO., LTD. (JP) | 1990-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037840-A1 | THERMOCLEAVABLE FRICTION MODIFIERS AND METHODS THEREOF | F12, F5, F3 | MMP1 683/4885MMP2 2609/4885MMP3 1101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.